Conjugates of a GM-CSF moiety and a polymer

Details for Australian Patent Application No. 2005275108 (hide)

Owner Nektar Therapeutics

Inventors Zhang, Ping; Bossard, Mary J.

Agent Griffith Hack

Pub. Number AU-B-2005275108

PCT Pub. Number WO2006/019950

Priority 60/588,601 16.07.04 US

Filing date 14 July 2005

Wipo publication date 23 February 2006

Acceptance publication date 12 May 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/019950 Priority application(s): WO2006/019950

25 February 2010 Assignment before Grant

  Nektar Therapeutics AL, Corporation The application has been assigned to Nektar Therapeutics

12 May 2011 Application Accepted

  Published as AU-B-2005275108

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005275131-Improved truck architecture

2005275107-Closure with liner seal vents